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The long and short of it: The adsorption of serum proteins <?><?>Title ok?<?><?>In protein-rich environments such as the blood, the formation of a protein corona on receptor-targeting nanoparticles prevents target recognition. As a result, the ability of targeted nanoparticles to selectively bind to diseased cells is drastically inhibited. Here, we demonstrate that backfilling the surface of a targeted nanoparticle with polyethylene glycol (PEG) molecules reduces the formation of the protein corona and re-establishes specific binding. The length of the backfilled PEG molecules must be less than the length of the ligand linker; otherwise, PEG interferes with the binding of the targeting ligand to its corresponding cellular receptor. <?><?>Ok?<?><?> Nanoparticles are being developed for the diagnosis and treatment of a variety of diseases. [1] The surfaces of these nanoparticles are typically functionalized with antibodies, [2] peptides, [3] or aptamers [4] that enable them to recognize specific receptors on cell surfaces. This allows the nanoparticles to selectively accumulate in diseased tissues, which could enhance the diagnostic sensitivity or therapeutic index while preventing accumulation in off-target tissues.<?><?>Sentence ok?<?><?> In order to improve the efficiency of nanoparticle delivery into diseased tissues, researchers have focused on understanding how targeted nanoparticles interact with biological components such as blood, [5] tissues, [6] and cells. [7] An emerging body of literature demonstrates that when nanoparticles are introduced into the blood, serum proteins interact with the nanoparticle surface to form a protein corona. [8] These adsorbed proteins affect nanoparticle pathophysiology [9] and mask the ability of targeted nanoparticles to interact with cell receptors, thereby leading to a loss of targeting specificity. [10] To suppress protein adsorption, researchers often functionalize the nanoparticle surface with the antifouling polymer polyethylene glycol (PEG). [11] In order to properly design target-specific nanoparticles, a detailed understanding of the amount of PEG to apply and the type of PEG to use is essential to effectively reduce serum protein-nanoparticle interactions.<?><?>Sentence ok?<?><?> To date, it is unclear whether PEG backfilling can improve the specific binding of nanoparticles to a targeted cell population by overcoming the inhibitory effect of the protein corona. In this study, we investigated whether backfilling receptor-targeting nanoparticles with PEG could suppress serum protein adsorption and re-establish binding specificity. We used gold nanoparticles as a model system because of their ease of synthesis and [12] characterization, [13] and their relevance in targeted delivery. [14] Herceptin was chosen as the biorecognition molecule because of its prevalent use for the therapeutic and diagnostic targeting of the ErbB2<?><?>ErbB2?
Change throughout? Yes, please. It has been changed<?><?> receptors in breast cancer. [15] Amines on the Herceptin molecule were labeled with the near-infrared-emitting dye Alexa Fluor 647 using amine-reactive succinimidyl ester chemistry. The high quantum yield and near-infrared emission of the Alexa Fluor dye minimizes gold surface quenching [16] Similar results were obtained by Salvati et^^al., where transferrin-targeted silica nanoparticles also experienced a reduction in binding specificity after exposure to serum. [11] Once we had confirmed that serum protein effectively reduced the targeting specificity of Herceptin-conjugated nanoparticles towards ErbB2<m+> cells, we wanted to determine whether backfilling the nanoparticles with thiolated PEG rescues the targeting specificity of the nanoparticles after exposure to serum protein. PEG groups are known to reduce nonspecific protein adsorption. [5] We hypothesize that nucleation of the protein corona occurs when there are available sites on the nanoparticle for the binding of serum proteins, which can catalyze the growth of the corona. To address this problem, we saturated the remaining bare surface of the nanoparticles with thiol-terminated PEG groups, followed by incubation with human serum. The thiolated PEG is datively bound to the nanoparticle surface because of the strong binding strength of sulfur to gold atoms. For nanoparticles that do not permit thiol--metal interactions, other linking chemistries such as click or carbodiimide chemistry may be used for backfilling the nanoparticle surface with PEG. [18] PEG backfilling effectively suppressed the adsorption of serum proteins to the surface of the nanoparticles (Figures^^S5B,^S7). In the first set of experiments, we used a 2^^kDa thiol-terminated mPEG for backfilling the Herceptin-conjugated gold nanoparticles. When introduced to cells, these backfilled nanoparticles were shown to be 2.5-fold more responsive to SKBR3 cells than MCF7 cells, with specificity indices of 3.07 and 1.24 (Figure^^1^E<xfigr1>), respectively. This result suggests that mPEG backfilling can partially rescue the specificity of the nanoparticles for ErbB2 receptors after exposure to serum. 
